Invesaro

Stocks CSCO Financial statements

Financial statements

CISCO SYSTEMS, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data CISCO SYSTEMS, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue48,00549,33051,90449,30149,81851,55756,99853,80356,65463,325
Cost of revenue17,78118,72419,23817,61817,92419,30921,24518,97519,86422,465
Gross profit30,22430,60632,66631,68331,89432,24835,75334,82836,79040,860
Research and development6,0596,3326,5776,3476,5496,7747,5517,9839,3009,563
Selling and marketing9,1849,2429,5719,1699,2599,0859,88010,36410,96611,559
General and administrative1,9932,1441,8271,9252,1522,1012,4782,8132,9922,761
Operating expenses18,25118,29718,44718,06319,06118,27920,72222,64725,03025,492
Operating income11,97312,30914,21913,62012,83313,96915,03112,18111,76015,368
Interest expense8619438595854343604271,0061,5931,470
Interest income1,3381,5081,3089206184769621,3651,001866
Other non-operating income31473035235042950828753-660641
Pre-tax income12,28713,03914,57113,97013,26214,47715,31812,23411,10016,009
Income tax2,67812,9292,9502,7562,6712,6652,7051,9149202,742
Net income9,60911011,62111,21410,59111,81212,61310,32010,18013,267
EBITDA13,07313,40915,21914,52013,63314,76915,73112,88112,46016,068
EPS, basic1.920.022.632.652.512.833.082.552.563.36
EPS, diluted1.900.022.612.642.502.823.072.542.553.33
Shares, basic (weighted)5,0104,8374,4194,2364,2224,1704,0934,0433,9763,953
Shares, diluted (weighted)5,0494,8814,4534,2544,2364,1924,1054,0623,9983,987
Dividend per share1.101.241.361.421.461.501.541.581.621.66

Balance sheet

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash and equivalents11,7088,93411,75011,8099,1757,07910,1237,5088,3467,218
Short-term investments37,61421,66317,61015,34312,18816,02310,3467,7648,700
Receivables5,1465,5545,4915,4725,7666,6225,8546,6856,7017,470
Inventory1,6161,8461,3831,2821,5592,5683,6443,3733,1645,694
Other current assets1,5932,9402,3732,3492,8894,3554,3525,6125,9506,191
Total current assets83,70361,83747,75543,57339,11236,71743,34836,86234,98638,665
Property, plant and equipment3,3223,0062,7892,4532,3381,9972,0852,0902,1132,760
Lease right-of-use assets9211,0951,0039711,0661,3011,395
Goodwill29,76631,70633,52933,80638,16838,30438,53558,66059,13659,477
Intangible assets2,5392,5522,2011,5763,6192,5691,81811,2199,1757,557
Other non-current assets1,5111,5822,4963,7415,0165,9576,0075,9446,0599,129
Total assets129,818108,78497,79394,85397,49794,002101,852124,413122,291129,637
Accounts payable1,3851,9042,0592,2182,3622,2812,3132,3042,5283,366
Accrued liabilities2,8952,9863,2213,1223,8183,3163,9843,6083,6114,057
Deferred revenue10,82111,49010,66811,40612,14812,78413,90816,24916,41616,988
Short-term debt7,9925,23810,1913,0052,5081,0991,73311,3415,23210,161
Total current liabilities27,58327,03531,71225,33126,25725,64031,30940,58435,06441,525
Long-term debt25,72520,33114,47511,5789,0188,4166,65819,62122,86119,372
Lease liabilities6618317247079061,1751,248
Other non-current liabilities1,4501,4341,3092,1472,3931,9682,1342,5402,9953,323
Total liabilities63,68165,58064,22256,93356,22254,22957,49978,95675,44879,352
Total debt30,47225,56920,47314,58311,5268,9158,39120,10924,61122,872
Paid-in capital45,25342,82040,26641,20242,34642,71444,28945,80047,74749,676
Retained earnings20,8381,233-5,903-2,763-654-1,3191,6391,087501,565
Other comprehensive income46-849-792-519-417-1,622-1,575-1,430-954-956
Shareholders' equity66,13743,20433,57137,92041,27539,77344,35345,45746,84350,285
Minority interests000
Total equity66,13743,20433,57137,92041,27539,77344,35345,45746,84350,285
Total liabilities and equity129,818108,78497,79394,85397,49794,002101,852124,413122,291129,637
Shares outstanding4,9834,6144,2504,2374,2174,1104,0664,0073,9603,946

Cash flow statement

FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Net income9,60911011,62111,21410,59111,81212,61310,32010,18013,267
Depreciation and amortization1,1001,1001,000900800800700700700700
Stock-based compensation1,5261,5761,5701,5691,7611,8862,3533,0743,6413,830
Deferred income tax-124900-350-38-384-309-2,085-972-1,133226
Change in receivables756-269-84-107-107-1,009734-289-22-832
Change in inventory-394-24413184-244-1,030-1,069275209-2,541
Change in payables31150487141-53-5527-90257842
Cash from operations13,87613,66615,83115,42615,45413,22619,88610,88014,19314,177
Capital expenditures-964-834-909-770-692-477-849-670-905-1,410
Acquisitions-3,324-3,006-373-301-25,994-291-516
Purchases of investments-42,702-14,285-2,416-9,212-9,328-6,070-10,871-4,230-4,589-8,974
Sales and maturities of investments12,14315,76912,9287,9758,4095,6865,9786,3674,9436,105
Cash from investing-6,03615,31814,8373,500-5,2851,553-5,107-20,4781,733-3,484
Debt issued6,9806,8772,250001,049031,81819,29213,048
Debt repaid-4,151-12,375-6,780-6,720-3,000-3,550-500
Stock issued708623640655643660700714736805
Share buybacks-3,685-17,547-20,717-2,659-2,877-7,689-4,293-5,787-6,000-6,106
Dividends paid-5,511-5,968-5,979-6,016-6,163-6,224-6,302-6,384-6,437-6,553
Cash from financing-3,806-31,764-27,889-18,856-12,097-15,962-11,6266,844-15,815-12,347
Net change in cash4,034-2,7802,77940-1,870-1,3633,048-2,78568-1,683
Free cash flow12,91212,83214,92214,65614,76212,74919,03710,21013,28812,767
Interest paid8979118926034383553765831,500
Income taxes paid2,7423,9112,9863,1163,6043,6633,5717,4003,9004,821

Key metrics

Worked out from the statements above. Latest values use fiscal 2026. Valuation uses the share price of $106.70 on September 25, 2026.

Profitability

MetricValueHow it is calculated
Gross margin64.5%Gross profit / revenue.
Operating margin24.3%Operating income / revenue.
EBITDA margin25.4%EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin25.3%Pre-tax income / revenue.
Net margin21.0%Net income / revenue.
FCF margin20.2%Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin22.4%Cash from operations / revenue.
Effective tax rate17.1%Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)27.3%Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)10.5%Net income / average total assets.
Return on invested capital (ROIC)19.7%Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue15.1%Research and development expense / revenue.
Stock-based pay / revenue6.0%Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue2.2%Capital expenditures / revenue.
D&A / revenue1.1%Depreciation and amortization / revenue.

Growth

MetricValueHow it is calculated
Revenue growth, 1y11.8%Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y3.6%Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y4.9%Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y11.1%Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y4.6%Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y5.1%Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y30.7%Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y0.7%Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y3.7%Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y29.0%EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y0.7%Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y3.3%Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y30.3%Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y1.7%Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y4.6%Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y30.6%EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y2.7%Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y5.9%Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y-0.1%Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y-10.7%Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y-1.7%Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y-3.9%Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y-12.5%Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y-2.9%Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y2.5%Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y2.5%Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y2.6%Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y7.3%Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y4.3%Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y4.0%Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y6.0%Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y8.4%Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y5.9%Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y-0.3%Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y-1.0%Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y-1.2%Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

MetricValueHow it is calculated
Current ratio0.93xCurrent assets / current liabilities.
Quick ratio0.56x(Cash + short-term investments + receivables) / current liabilities.
Cash ratio0.38x(Cash + short-term investments) / current liabilities.
Debt / equity0.45xTotal debt / shareholders' equity. Not shown when equity is negative.
Debt / assets17.6%Total debt / total assets.
Liabilities / assets61.2%Total liabilities / total assets.
Net debt$6.95BTotal debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA0.43xNet debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage10.5xOperating income / interest expense.
Working capital-$2.86BCurrent assets - current liabilities.
Goodwill and intangibles / assets51.7%(Goodwill + intangible assets) / total assets.
Tangible book value-$16.75BShareholders' equity - goodwill - intangible assets.

Efficiency

MetricValueHow it is calculated
Asset turnover0.50xRevenue / average total assets.
Fixed asset turnover26.0xRevenue / average property, plant and equipment.
Inventory turnover5.07xCost of revenue / average inventory.
Days inventory72 days365 x average inventory / cost of revenue.
Receivables turnover8.94xRevenue / average receivables.
Days sales outstanding41 days365 x average receivables / revenue.
Days payables48 days365 x average accounts payable / cost of revenue.
Cash conversion cycle65 daysDays inventory + days sales outstanding - days payables.
FCF conversion96.2%Free cash flow / net income, when net income is positive.
Capex / operating cash flow9.9%Capital expenditures / cash from operations, when that is positive.

Per share

MetricValueHow it is calculated
EPS, diluted$3.33Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic$3.36Net income per basic share, as reported (split-adjusted).
Revenue per share$15.88Revenue / diluted weighted shares.
FCF per share$3.20Free cash flow / diluted weighted shares.
Operating cash flow per share$3.56Cash from operations / diluted weighted shares.
Book value per share$12.74Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share-$4.24Tangible book value / shares outstanding.
Cash per share$4.03(Cash + short-term investments) / shares outstanding.
Dividend per share$1.66Dividend declared per common share (paid, when declared is not tagged).
Payout ratio49.4%Dividends paid / net income, when net income is positive.
Dividends / FCF51.3%Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF47.8%Share buybacks / free cash flow, when free cash flow is positive.

Valuation

MetricValueHow it is calculated
Market cap$420.55BShare price x shares outstanding.
Enterprise value$427.51BMarket cap + total debt - cash - short-term investments.
P/E31.7xMarket cap / net income. Only when net income is positive.
P/S6.64xMarket cap / revenue.
P/B8.36xMarket cap / shareholders' equity. Only when equity is positive.
P/FCF32.9xMarket cap / free cash flow. Only when free cash flow is positive.
P/OCF29.7xMarket cap / cash from operations, when positive.
EV/Sales6.75xEnterprise value / revenue.
EV/EBIT27.8xEnterprise value / operating income, when both are positive.
EV/EBITDA26.6xEnterprise value / EBITDA, when both are positive.
EV/FCF33.5xEnterprise value / free cash flow, when both are positive.
FCF yield3.0%Free cash flow / market cap.
Earnings yield3.2%Net income / market cap (the inverse of P/E).
Dividend yield1.6%Dividends paid over the period / market cap.
Shareholder yield3.0%(Dividends paid + share buybacks) / market cap.
PEG11.5xP/E / EPS growth per year over 3 years (in percent). Only when both are positive.
What was CISCO SYSTEMS, INC.'s revenue in fiscal 2026?

CISCO SYSTEMS, INC. reported revenue of $63.33B for fiscal 2026, 11.8% higher than the year before.

Was CISCO SYSTEMS, INC. profitable in fiscal 2026?

Yes. Net income was $13.27B, a net margin of 21%.

How much free cash flow did CISCO SYSTEMS, INC. generate in fiscal 2026?

Cash from operations of $14.18B minus capital expenditures of $1.41B left free cash flow of $12.77B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to CISCO SYSTEMS, INC.